<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83824">
  <stage>Registered</stage>
  <submitdate>30/07/2009</submitdate>
  <approvaldate>21/10/2009</approvaldate>
  <actrnumber>ACTRN12609000910202</actrnumber>
  <trial_identification>
    <studytitle>The effectiveness of Cognitive Processing Therapy (CPT) for Veterans' and Veterans' Families Counselling Service (VVCS) clients with Posttraumatic Stress Disorder (PTSD)</studytitle>
    <scientifictitle>The effectiveness of Cognitive Processing Therapy (CPT) for Veterans' and Veterans' Families Counselling Service (VVCS) clients with Posttraumatic Stress Disorder (PTSD)</scientifictitle>
    <utrn />
    <trialacronym>CPT Trial</trialacronym>
    <secondaryid>Not applicable</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Posttraumatic Stress Disorder</healthcondition>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Anxiety</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Cognitive Processing Therapy.
Total of 12 1hour sessions, delivered twice a week for 6 weeks. One-on-one therapy administered by a trained psychologist or social worker.</interventions>
    <comparator>Treatment as Usual; comprising usual treatment. Treatment may involve supportive counselling, relaxation or cognitive behaviour therapy (CBT). Session content is monitored for the same period as the CPT intervention.</comparator>
    <control>Active</control>
    <interventioncode>Behaviour</interventioncode>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>PTSD Severity 
Clinician-Administered PTSD Scale and PTSD Checklist  (PCL-S)</outcome>
      <timepoint>Imediately post treatment, 3 months post treatment</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Depression:
Mini International Neuropsychiatric Interview Version 5.5 (M.I.N.I) Module A
Beck Depression Inventory Second Edition (BDI-II)</outcome>
      <timepoint>Imediately post treatment, 3 months post treatment</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Anxiety:
State-Trait Anxiety Inventory (STAI) State-Scale only</outcome>
      <timepoint>Imediately post treatment, 3 months post treatment</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Anger:
Dimensions of Anger Reactions (DAR7)</outcome>
      <timepoint>Imediately post treatment, 3 months post treatment</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Alcohol use:
Alcohol Use Disorders Identification Test (AUDIT)</outcome>
      <timepoint>Imediately post treatment, 3 months post treatment</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Social Functioning/ Relationships
Abbreviated Dyadic Adjustment Scale (ADAS)</outcome>
      <timepoint>Imediately post treatment, 3 months post treatment</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Quality of Life:
WHOQOL-Br?f (World Health Organization Quality of Life- short from)</outcome>
      <timepoint>Imediately post treatment, 3 months post treatment</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Traumatic Thoughts:
Post Traumatic Cognitions Inventory (PTCI)</outcome>
      <timepoint>Imediately post treatment, 3 months post treatment</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Veteran/former Australia Defence Force (ADF) member irrespective of age or theatre of conflict
Diagnosis of PTSD or Subsyndromal PTSD on Clinician Administered PTSD Scale  (CAPS) (subsyndromal defined as at least one criterion in each symptom cluster  as per (Mylle &amp; Maes, 2004), plus full criterion in two of the three symptom clusters) Stable medications for 4 weeks prior to trial entryi.e. prescribed medication must have been the same for the last 4 weeks with no anticipated changes during the upcoming 12 weeks (if prescription has changed, or is under review, delay study enrolment until medications are stable)
A reasonable comprehension of English (defined by proficiency to read and understand the participant information sheet and consent form).</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Current uncontrolled psychotic or bipolar disorder
Prominent current suicidal or homicidal ideation
Current Substance dependence at a level likely to impede treatment.   
Significant cognitive impairment</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Participants are assessed by an independent blind assessor. The outcome of the intake/eligibility assessment is reported to the project manager who allocates randomly to a. therapist for  experimentalor active control treatment. The relevant therapist contacts the client to begin treament. The assessor is naive to all further treatment activity after assessment.</concealment>
    <sequence>Computer generated random number sequence. Stratified by site (Brisbane Melbourne Adelaide)</sequence>
    <masking>Open (masking not used)</masking>
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/01/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>Australian Government Department of Veteran Affairs</primarysponsorname>
    <primarysponsoraddress>Department of Veteran Affairs
Po Box 21
Wooden
ACT 2606</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Australian Government Department of Veteran Affairs</fundingname>
      <fundingaddress>Department of Veteran Affairs
Po Box 21
Wooden
ACT 2606</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Government body</sponsortype>
      <sponsorname>Australian Government Department of Veteran Affairs</sponsorname>
      <sponsoraddress>Department of Veteran Affairs
Po Box 21
Wooden
ACT 2606</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Department of Veteran Affairs Human Research Ethics Committee (DVA HREC)</ethicname>
      <ethicaddress>HREC Coordinator
Department of Veterans' Affairs
PO Box 21
Woden ACT 2606</ethicaddress>
      <ethicapprovaldate>28/04/2006</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>David Forbes</name>
      <address>Australian Centre for Posttraumatic Mental Health
Level 1, 340 Albert Street 
East Melbourne
Victoria 3002</address>
      <phone>+61 3 9936 5159</phone>
      <fax>+61 3 9936 5199</fax>
      <email>d.lloyd@unimelb.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Delyth Lloyd</name>
      <address>Delyth Lloyd
Project Manager
Australian Centre for Posttraumatic Mental Health
Level 1, 340 Albert Street 
East Melbourne
Victoria 3002</address>
      <phone>+61 3 9936 5162</phone>
      <fax>+61 3 9936 5199</fax>
      <email>d.lloyd@unimelb.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Delyth Lloyd</name>
      <address>Delyth Lloyd
Project Manager
Australian Centre for Posttraumatic Mental Health
Level 1, 340 Albert Street 
East Melbourne
Victoria 3002</address>
      <phone>+61 39936 5162</phone>
      <fax>+61 3 9936 5199</fax>
      <email>d.lloyd@unimelb.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>